Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDCME: Practicing Precision in ALK and ROS1 Rearrangement Positive Non-Small Cell Lung Cancer (NSCLC): Testing, Targets, and Treatments

This one-credit activity features an expert panel providing their perspectives on the latest trends and emerging research regarding biomarker testing and evidence-based biomarker-guided targeted therapy for patients with NSCLC with ROS1 and ALK rearrangements.